Asia Pacific Genital Warts Market Report – Industry Trends and Forecast to 2028

Asia-Pacific Genital Warts Market, By Morphology (Cauliflower-Like, Smooth Papular, Keratotic, and Flat Warts), Type (Prevention, Diagnostics, Treatment), Cause (HPV 6, HPV 11, Others), Location (Vulva, Cervix Uteri, Urethra, Anus, Scrotum), Gender (Male and Female), Dosage (Cream, Gel, Ointment, Intramuscularly and Others), End-User (Hospitals, Diagnostic Centers, Surgical Centers, Ambulatory Surgical Centers, and Others), Distribution Channel (Direct Tender, Pharmacy Stores and Others), By Country (China, Japan, India, South Korea, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines and Rest of Asia-Pacific) Industry Trends & Forecast to 2028.

Market Analysis and Insights: Asia Pacific Genital Warts Market

Asia Pacific genital warts market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses that the market is growing with a CAGR of 8.4% in the forecast period of 2021 to 2028 and is expected to reach USD 2,111.50 million by 2028 from USD 1,139.36 million in 2020.

Genital warts are one of the most recurrent types of sexually transmitted infections. The human papillomavirus is the virus responsible for causing genital warts. People will get infected with at least one type of human papillomavirus (HPV) at some point during their lives. Genital warts affect most of the moist tissues in the genital areas of male and female patients. Although the genital infection is asymptomatic, it's frequently recognized as genital warts due to the onset of symptoms. It is estimated that around 1% of sexually active men and women in the United States have genital warts.

Genital warts are caused due to the human papillomavirus (HPV). There are around 30-40 strains of HPV. However, only a few of the strains cause genital warts. The virus is easily transmittable through skin-to-skin contact. Hence it's considered a sexually transmitted infection (STI). The Center for Disease Control and Prevention (CDC) says that people get genital warts due to the mutant activity of HPV.

The prevalence of sexually transmitted diseases (STDs) and human papillomavirus infections in China, the rise in the female population, the awareness programs by healthcare organizations in India to inculcate awareness about the prevention of STDs are expected to drive the genital warts market. Moreover, the increase in clinical trials, rise in healthcare expenditure and strategic initiatives by market players, and huge market potential in developing countries bolsters the genital warts market growth. However, the increased cost of treatment for genital warts, the side effects noticed while undergoing treatment for genital warts, and lack of patient awareness are the restraints that could hinder the growth of the genital warts market. The rise in product recalls associated with the vaccines and patient compliance regarding the use of vaccines are the restraints that could hinder the market growth.

However, a lack of skilled and qualified professionals could pose a challenge to the growth of the genital warts market.

The Asia-Pacific genital warts market report provides details of market share, new developments, and impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the market scenario, contact us for an Analyst Brief. Our team will help you create a revenue impact solution to achieve your desired goal.

Asia- Pacific Genital Warts Market Scope and Market Size

Asia- Pacific genital warts market is segmented on the basis of morphology, type, cause, location, gender, dosage, end-user, and distribution channel. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

On the basis of morphology, the Asia -Pacific genital warts market is segmented into flat warts, smooth papular, cauliflower-like, and keratotic. In 2021, the cauliflower-like segment is expected to dominate the Asia -Pacific genital warts market due to the high prevalence of this shape of genital warts, and the cauliflower morphology appears more in the patients of Japan.

On the basis of type, the Asia -Pacific genital warts market is segmented into prevention, diagnostics, and treatment. In 2021, the prevention segment is expected to dominate the Asia -Pacific genital warts market as prevention is increased due to the availability of preventive vaccines in Japan and India and ongoing clinical trials in the Asia region.

On the basis of cause, the Asia -Pacific genital warts market is segmented into HPV 6, HPV 11, and others. In 2021, the HPV 6 segment is expected to dominate the Asia -Pacific genital warts market owing to the HPV 6 strain having the highest abundance in the diagnostics and have a higher prevalence rate than HPV 11.

On the basis of location, the Asia -Pacific genital warts market is segmented into cervix uteri, urethra, anus, vulva, and scrotum. In 2021, the vulva segment is expected to dominate the Asia -Pacific genital warts market because the because prevalence rate in women is higher than in men.

On the basis of gender, the Asia -Pacific genital warts market is segmented into male and female. In 2021, the female segment is expected to dominate the Asia -Pacific genital warts market due to the higher prevalence or incidence rate, and the male patients of the region have less incidence rate than women.

On the basis of dosage, the Asia -Pacific genital warts market is segmented into cream, gel, ointment, intramuscularly, and others. In 2021, the cream segment is expected to dominate the Asia -Pacific genital warts market because treatment with topical imiquimod provides safety and efficacy and is easily available in hospital pharmacies and chemist stores.

On the basis of end-user, the Asia -Pacific genital warts market is segmented into hospitals, diagnostic centers, surgical centers, ambulatory surgical centers, and others. In 2021, the hospitals' segment is expected to dominate the Asia -Pacific genital warts market due to technological advancements in hospital and diagnostic centers for the treatment of genital warts and the presence of well-trained dermatologists for the diagnosis and treatment of genital warts.

On the basis of distribution channels, the Asia -Pacific genital warts market is segmented into direct tender, pharmacy stores, and others. In 2021, the direct tender segment is expected to dominate the Asia -Pacific genital warts market as there is no requirement of the prescription of doctors , competitive selection of wholesalers and management of net sales.

Asia-Pacific Genital Warts market Country Level Analysis

The Asia-Pacific genital warts market is analyzed, and market size information is provided by-products, wound type, method, and end-user.

The countries covered in the genital warts market report are Japan, China, India, South Korea, Australia, Singapore, Indonesia, the Philippines, and the rest of the Asia-Pacific.

China is expected to grow with the highest CAGR in the forecasted periods in the Asia-Pacific's regions as the demand for genital warts products is increasing very rapidly with urbanization and laboratory automation for the diagnosis of genital warts. China is also one of the leading countries to inculcate genital warts market.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impact the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts, and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, the presence and availability of Asia Pacific brands and their challenges faced due to large or scarce competition from local and domestic brands, the impact of sales channels are considered while providing forecast analysis of the country data.

The Growth Potential For Genital Warts Emerging Economies And The Strategic Initiatives By Market Players Are Creating New Opportunities In The Asia-Pacific Genital Wartsmarket

Asia Pacific genital warts market also provides you with detailed market analysis for every country's growth in a particular industry with genital warts treatment product sales, the impact of advancement in genital warts, and changes in regulatory scenarios with their support for the genital warts market. The data is available for the historic period 2010 to 2019.

Competitive Landscape and Asia Pacific Genital wartsMarket Share Analysis

Asia Pacific genital warts market competitive landscape provides details by a competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width, and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the company's focus related to the genital warts market.

The major companies providing the Asia- Pacific genital warts are Bausch Health Companies Inc, Merck Sharpe & Dohme Corp., (a subsidiary of Merck & Co., Inc.), Taro Pharmaceutical Industries Ltd, Glenmark Pharmaceutical Inc., USA (a subsidiary of Glenmark Pharmaceuticals Ltd.), GlaxoSmithKline plc, Serum Institute of India Pvt. Ltd, Fotona, Orgenesis Inc, Perrigo Company plc, among others.

DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

The strategic initiatives by market players along with new technological advancements for genital warts are bridging the gap for chronic wounds treatment.

For instance,

In February 2020, Bausch Health Companies Inc. and its dermatology business, Ortho Dermatologics, had launched the telemedicine platform on the dermatology.com portal, which is non-reimbursed for the cash pay prescription program in the U.S. The launch of the telemedicine platform would offer the patients an opportunity to consult with a healthcare expert regarding the recommendation of the safety and availability of the topical medications, such as SOLODYN (minocycline hydrochloride) extended-release tablets, EFUDEX (fluorouracil) topical cream, 5% and ALDARA (imiquimod) cream, 5%. It would result in timely treatment of the patients and increased awareness about the product

Collaboration, joint ventures, and other strategies by the market player are enhancing the company market in the genital warts market, which also provides the benefit for an organization to improve their offering for the genital warts market.

SKU-64294

Research Methodology:

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Customization Available:

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Asia Pacific Genital Warts Market – Industry Trends and Forecast to 2028

Market Analysis and Insights: Asia Pacific Genital Warts Market

Asia- Pacific Genital Warts Market Scope and Market Size

Asia-Pacific Genital Warts market Country Level Analysis

Competitive Landscape and Asia Pacific Genital wartsMarket Share Analysis

SKU-64294

Please fill in the below form for Infographics

Research Methodology:

Please fill in the below form for Research Methodology

Customization Available:

Please fill in the below form for Available Customization

Frequently Asked Questions

Browse Related Reports

Browse Related Blogs

Browse Related Press Release

FOLLOW US ON

REPORTS

MARKET INSIGHT

SUPPORT

SOLUTIONS